Back to Blog

1 min read

Reed Jobs: A New Era in Cancer Treatment

Reed Jobs prefers to focus on cancer treatment rather than his last name.

  • Biotechnology
  • Artificial Intelligence
  • Cancer Treatment

Reed Jobs, choosing to focus on curing cancer rather than discussions surrounding his last name, is paving a new path in the biotech industry. In the nearly three years since we last spoke at TechCrunch Disrupt, his venture, Yosemite, has grown rapidly into a team of 17. The biotechnology sector is on the brink of newfound opportunities as several blockbuster drugs face patent expirations in the coming years.

Jobs noted, "I didn't expect Yosemite to be moving this fast," highlighting the speed at which his organization has evolved. Artificial intelligence has transitioned from a mere curiosity to a significant component of Yosemite’s operations, presenting revolutionary potential in the biotech space. Reed Jobs' emphasis on cancer treatment reflects a personal struggle and a desire to create societal change, making the future of health technologies and AI integration an exciting frontier to watch.

Related Posts

Apple launches new app to study AI use in health

Apple has launched a new app to study how people use artificial intelligence for health.

Apple, Health, Artificial Intelligence

News brief1 min read

PSI is Trying to Build a Business Around AI-Driven Scientific Discovery

PSI is exploring business opportunities in the field of AI-driven scientific discovery.

Artificial Intelligence, Science

News brief1 min read

Meta Warns Election Backlash Against Data Centers Could Hinder AI Expansion

Meta warns that growing political opposition to data centers could threaten future AI investments.

Meta, Artificial Intelligence, Data Centers

News brief1 min read

Subscribe to Newsletter

Get the latest tech news and blog posts delivered to your inbox.